Linning Yu

792 citations

14 papers · 593 indexed · h-index 13

Impact in

Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
Toxicology top 5%
- Bioactive Compounds and Antitumor Agents

Papers in ⓘ

Molecular Biology 5
- Genomics, phytochemicals, and oxidative stress 2
Toxicology 5
- Bioactive Compounds and Antitumor Agents 5

Co-authors: Judy L. Bolton (7 shared papers)Abdul Mutlib (5 shared papers)Richard B. van Breemen (4 shared papers)Joe Palandra (2 shared papers)Timothy G. Brayman (2 shared papers)Joseph A. Ware (2 shared papers)Anis A. Khan (2 shared papers)Hani Zaher (2 shared papers)
Journals: Chemical Research in Toxicology (9 papers)Molecular Pharmaceutics (1 paper)The FASEB Journal (1 paper)Drug Metabolism and Disposition (1 paper)Methods in enzymology on CD-ROM/Methods in enzymology (1 paper)
Partner nations: United States Canada

In The Last Decade

Linning Yu

14 papers receiving 574 citations

Peers

Countries citing papers authored by Linning Yu

Since Specialization

Citations

This map shows the geographic impact of Linning Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linning Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linning Yu more than expected).

Fields of papers citing papers by Linning Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linning Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linning Yu. The network helps show where Linning Yu may publish in the future.

Co-authors

The 25 scholars most cited alongside Linning Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Linning Yu Line = papers co-authored together Linning Yu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work
1	Breast Cancer Resistance Protein (Bcrp/abcg2) Is a Major Determinant of Sulfasalazine Absorption and Elimination in the Mouse Molecular Pharmaceutics ·Hani Zaher, Anis A. Khan, Joe Palandra, Timothy G. Brayman, Linning Yu, Joseph A. Ware	2006	123
2	Nuclear Magnetic Resonance Spectroscopy as a Quantitative Tool To Determine the Concentrations of Biologically Produced Metabolites: Implications in Metabolites in Safety Testing Chemical Research in Toxicology ·Robert Espina, Linning Yu, Jianyao Wang, Zeen Tong, Sarvesh C. Vashishtha, Rasmy Talaat, JoAnn Scatina, Abdul Mutlib	2008	72
3	Oxidation of Raloxifene to Quinoids: Potential Toxic Pathways via a Diquinone Methide and o-Quinones Chemical Research in Toxicology ·Linning Yu, Hong Liu, Wenkui Li, Fagen Zhang, Connie Luckie, Richard B. van Breemen, Gregory R. J. Thatcher, Judy L. Bolton	2004	65
4	Obtaining Exposures of Metabolites in Preclinical Species through Plasma Pooling and Quantitative NMR: Addressing Metabolites in Safety Testing (MIST) Guidance without Using Radiolabeled Compounds and Chemically Synthesized Metabolite Standards Chemical Research in Toxicology ·Karthick Vishwanathan, Kathlene Babalola, Jack Wang, Robert Espina, Linning Yu, Adedayo Adedoyin, Rasmy Talaat, Abdul Mutlib, JoAnn Scatina	2008	61
5	Identification of Novel Electrophilic Metabolites of Piper methysticum Forst. (Kava) Chemical Research in Toxicology ·Benjamin M. Johnson, Sheng-Xiang Qiu, Shide Zhang, Fagen Zhang, Joanna E. Burdette, Linning Yu, Judy L. Bolton, Richard B. van Breemen	2003	53
6	Characterization of HKI-272 Covalent Binding to Human Serum Albumin Drug Metabolism and Disposition ·Jianyao Wang, Xiao Xian Li-Chan, Jim Atherton, Linhong Deng, Robert Espina, Linning Yu, Peter Horwatt, Steven M. Ross, Susan Lockhead, Syed Sayeed Ahmad, Appavu Chandrasekaran, Aram Oganesian, JoAnn Scatina, Abdul Mutlib, Rasmy Talaat	2010	51
7	A Rational Chemical Intervention Strategy To Circumvent Bioactivation Liabilities Associated with a Nonpeptidyl Thrombopoietin Receptor Agonist Containing a 2-Amino-4-arylthiazole Motif Chemical Research in Toxicology ·Amit S. Kalgutkar, James P. Driscoll, Sabrina X. Zhao, Gregory S. Walker, Richard M. Shepard, John R. Soglia, James Atherton, Linning Yu, Abdul Mutlib, Michael J. Munchhof, Lawrence A. Reiter, Christopher S. Jones, Johnathan L. Doty, Kristen A. Trevena, Christopher L. Shaffer, Sharon L. Ripp	2007	38
8	Synthesis and Reactivity of Potential Toxic Metabolites of Tamoxifen Analogues: Droloxifene and Toremifene o-Quinones Chemical Research in Toxicology ·Dan Yao, Fagen Zhang, Linning Yu, Ya‐Nan Yang, Richard B. van Breemen, Judy L. Bolton	2001	33
9	Bioactivation of Lamotrigine in Vivo in Rat and in Vitro in Human Liver Microsomes, Hepatocytes, and Epidermal Keratinocytes: Characterization of Thioether Conjugates by Liquid Chromatography/Mass Spectrometry and High Field Nuclear Magnetic Resonance Spectroscopy Chemical Research in Toxicology ·Hao Chen, Scott D. Grover, Linning Yu, Gregory S. Walker, Abdul Mutlib	2009	22
10	Quinoids Formed from Estrogens and Antiestrogens Methods in enzymology on CD-ROM/Methods in enzymology ·Judy L. Bolton, Linning Yu, Gregory R. J. Thatcher	2004	22
11	Equine estrogen metabolite 4-hydroxyequilenin induces anchorage-independent growth of human mammary epithelial MCF-10A cells: differential gene expression Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Muriel Cuendet, Xuemei Liu, Emily Pisha, Yan Li, Jiaqin Yao, Linning Yu, Judy L. Bolton	2004	21
12	Nitrosation, Nitration, and Autoxidation of the Selective Estrogen Receptor Modulator Raloxifene by Nitric Oxide, Peroxynitrite, and Reactive Nitrogen/Oxygen Species Chemical Research in Toxicology ·Violeta Toader, Xudong Xu, Adrian C. Nicolescu, Linning Yu, Judy L. Bolton, Gregory R. J. Thatcher	2003	17
13	Equine Catechol Estrogen 4-Hydroxyequilenin Is a More Potent Inhibitor of the Variant Form of Catechol-O-Methyltransferase Chemical Research in Toxicology ·Yan Li, Jiaqin Yao, Minsun Chang, Dejan Nikolić, Linning Yu, James D. Yager, Andrew D. Mesecar, Richard B. van Breemen, Judy L. Bolton	2004	13
14	Breast Cancer Resistance Protein (BCRP/ABCG2) is a Major Determinant of Sulfasalazine Absorption and Elimination in the Mouse The FASEB Journal ·Hani Zaher, Anis A. Khan, Joe Palandra, Timothy G. Brayman, Linning Yu, Joseph A. Ware	2006	2

About Linning Yu

Linning Yu is a scholar working on Molecular Biology, Toxicology, Genetics, Pharmacology and Pharmacology, having authored 14 papers that have together received 593 indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (5 papers), Estrogen and related hormone effects (5 papers), Pharmacological Effects and Toxicity Studies (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Inflammatory mediators and NSAID effects (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Computational Drug Discovery Methods (1 paper). The work is most often cited by research in Pharmacology (172 citations), Toxicology (58 citations), Oncology (163 citations), Complementary and alternative medicine (43 citations) and Pediatrics, Perinatology and Child Health (78 citations). Linning Yu has collaborated with scholars based in United States and Canada. Frequent co-authors include Judy L. Bolton, Abdul Mutlib, Richard B. van Breemen, Joe Palandra, Timothy G. Brayman, Joseph A. Ware, Anis A. Khan, Hani Zaher, Fagen Zhang and Robert Espina. Their work appears in journals such as Chemical Research in Toxicology, Molecular Pharmaceutics, The FASEB Journal, Drug Metabolism and Disposition and Methods in enzymology on CD-ROM/Methods in enzymology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact